XBI Dividend: Yield, Schedule, and What to Expect

Last updated July 2026

Short answer

XBI's approximate ~0.2% yield (as of mid-2026) makes it a growth-first, low-yield fund. It tracks S&P Biotechnology Select Industry Index and passes through the dividends of its holdings, typically quarterly, minus a 0.35% expense ratio. If income is your goal, look to dedicated dividend funds for more; XBI is built for total return, not yield. If total return is the goal, the yield matters less than cost and what it holds. Yield is a recent snapshot, not a promise; verify the current figure with State Street Global Advisors (SPDR).

How does the XBI dividend work?

XBI holds the companies in S&P Biotechnology Select Industry Index, collects the dividends they pay, and distributes them to shareholders (usually quarterly), net of its 0.35% fee. The yield you see is the trailing distributions divided by price, so it drifts as both change.

XBI tracks the S&P Biotechnology Select Industry Index, a modified equal-weighted basket of US biotech companies. It charges 0.35%. The key nuance versus the cap-weighted IBB is that XBI equal-weights its holdings, giving small and mid-cap drug developers far more sway and making it more volatile and less concentrated in a few large names.

How does XBI's dividend yield compare?

Approximate yield: ~0.2% (mid-2026).
What drives it: the payout of the underlying S&P Biotechnology Select Industry Index holdings.
Fee drag: the 0.35% expense ratio is deducted before you receive distributions.
For more income: dedicated dividend or income ETFs target higher yield, with their own trade-offs.

If income is your goal, compare XBI against dividend-focused funds. See the best dividend ETFs roundup, or analyze how XBI's income fits your real portfolio in Walnut.

The bottom line on the XBI dividend

The bottom line: at an approximate ~0.2% yield, XBI is a growth-first, low-yield fund. If income is your goal, dedicated dividend funds pay more; XBI is the wrong tool for yield and the right one for total-return S&P Biotechnology Select Industry Index exposure. If total return is the goal, the yield matters less than cost and what it holds. Treat the figure as a moving snapshot, not a fixed rate, and verify the current yield with State Street Global Advisors (SPDR).

Build a portfolio around XBI with Walnut

Use XBI as your core holding, then let Walnut's AI propose thematic satellites: AI infrastructure, dividend growth, clean energy, whatever you believe in. Connect your broker, build the basket in conversation, track it as one unit.

Create a free Walnut account

FAQ

What is XBI's dividend yield?

Approximately ~0.2% as of mid-2026. Yield moves with price and distributions, so treat it as a recent snapshot and verify the current figure on State Street Global Advisors (SPDR)'s fund page.

How often does XBI pay a dividend?

Most US equity ETFs like XBI distribute dividends quarterly, passing through the dividends their underlying holdings pay. Confirm the exact schedule and ex-dividend dates with State Street Global Advisors (SPDR).

Where does XBI's dividend come from?

XBI tracks S&P Biotechnology Select Industry Index and holds names such as MRNA, APGE, KYMR, VKTX, ERAS. The fund collects the dividends those companies pay and passes them to you, minus the 0.35% expense ratio.

Can I reinvest XBI dividends?

Yes. Most brokers let you turn on automatic dividend reinvestment (a DRIP) so XBI distributions buy more shares automatically. This compounds over time but still counts as taxable income in a taxable account.

Is XBI a good choice for dividend income?

Walnut is informational, not investment advice. XBI yields roughly ~0.2%, which is modest. Dedicated dividend ETFs target higher yield; broad-market funds prioritize total return over yield. Match the choice to whether you want income now or growth.

Are XBI dividends qualified?

Many dividends from a US large-cap equity ETF like XBI are qualified (taxed at lower long-term rates) if holding-period rules are met, but some portion can be ordinary. Tax treatment depends on your situation; confirm with a tax professional and State Street Global Advisors (SPDR)'s tax documents.

Walnut is informational, not investment advice. Dividend yields and schedules are approximate, stamped to mid-2026, and change; verify current figures with State Street Global Advisors (SPDR) or your broker.